Rituximab plus Peg-interferon-alpha/ribavirin compared with Peg-interferon-alpha/ribavirin in hepatitis C-related mixed cryoglobulinemia. - Wikidata - wikimedia - TriplyDB

Rituximab plus Peg-interferon-alpha/ribavirin compared with Peg-interferon-alpha/ribavirin in hepatitis C-related mixed cryoglobulinemia.

Rituximab plus Peg-interferon-alpha/ribavirin compared with Peg-interferon-alpha/ribavirin in hepatitis C-related mixed cryoglobulinemia.

http://www.wikidata.org/entity/Q50559814

about

Treatment for cryoglobulinemic and non-cryoglobulinemic peripheral neuropathy associated with hepatitis C virus infection Hepatitis C virus and neurological damage Extrahepatic manifestations of chronic hepatitis C virus infection Cutaneous manifestations of hepatitis C in the era of new antiviral agents Benign and Malignant Hematological Manifestations of Chronic Hepatitis C Virus Infection The place of immunotherapy in the management of HCV-induced vasculitis: an update Treatment of Hepatitis C in Patients Undergoing Immunosuppressive Drug Therapy Hepatitis C Therapy in Renal Patients: Who, How, When?Hepatitis C virus infection in nephrology patients Decreased expression of indoleamine 2,3-dioxygenase 1 in dendritic cells contributes to impaired regulatory T cell development in immune thrombocytopenia.Peg-IFNα/ribavirin/protease inhibitor combination in hepatitis C virus associated mixed cryoglobulinemia vasculitis: results at week 24 Managing refractory cryoglobulinemic vasculitis: challenges and solutions A case of rapid amelioration of hepatitis C virus-associated cryoglobulinemic membranoproliferative glomerulonephritis treated by interferon-free directly acting antivirals for HCV in the absence of immunosuppressant Hepatitis C virus associated glomerulopathies.Detection of low level cryoglobulins by flow cytometry.Hepatitis C and kidney disease: An overview and approach to management.Hepatitis C-related arthropathy: Diagnostic and treatment considerations.A randomized controlled trial of rituximab following failure of antiviral therapy for hepatitis C virus-associated cryoglobulinemic vasculitis.An additional line of therapy with pegylated interferon and ribavirin after rituximab in a patient with hepatitis C virus-related mixed cryoglobulinaemia and indolent non-Hodgkin's lymphoma previously treated with interferon Hepatitis C virus as a multifaceted disease: a simple and updated approach for extrahepatic manifestations of hepatitis C virus infection Successful and Safe Long-Term Standard Antiviral Therapy in a Patient with "Explosive" Immune Response in Course of HCV-Related Liver Cirrhosis Indolent B-cell lymphomas associated with HCV infection: clinical and virological features and role of antiviral therapy.Treatment of hepatitis C virus-associated mixed cryoglobulinemia with direct-acting antiviral agents.Hepatitis C virus, cryoglobulinemia, and kidney: novel evidence.New insights into HCV-related rheumatologic disorders: A review.An approach to the patient with retiform purpura.Laboratory testing for cryoglobulins.Update on the role of rituximab in kidney diseases and transplant.Rituximab in immunologic glomerular diseases.Management of rheumatic disease with comorbid HBV or HCV infection.Current treatment of hepatitis C-associated rheumatic diseases Antiviral therapy for HCV-associated cryoglobulinemic glomerulonephritis: case report and review of the literature.Viral hepatitis: review of arthritic complications and therapy for arthritis in the presence of active HBV/HCV.Antiviral therapy of symptomatic HCV-associated mixed cryoglobulinemia: meta-analysis of clinical studies.Hepatitis C virus-induced vasculitis: therapeutic options.Membranoproliferative glomerulonephritis, type II cryoglobulinemia and triple therapy for hepatitis C: a case series and review of the literature.Vasculitides and the Complement System: a Comprehensive Review.Virus-driven autoimmunity and lymphoproliferation: the example of HCV infection.Extrahepatic manifestations in chronic hepatitis C virus carriers.Combined treatment with antiviral therapy and rituximab in patients with mixed cryoglobulinemia: review of the literature and report of a case using direct antiviral agents-based antihepatitis C virus therapy.

P2860

Q24187162-7637D3A2-3C3D-42E1-980D-033670182D83 Q26748575-F6131206-2FC9-4F85-90C5-C4DEE6A99F15 Q26767084-19177BED-1A93-413E-B83B-DEE99CD707E5 Q26773669-C3C995EE-CB9C-46AC-AA8C-C16B89FEE7EF Q26775733-F450A0F3-5380-40B7-9B33-336F885048C6 Q27015124-DC7FD5E6-1D5B-4D2A-BB7D-A13CF2B0364D Q28073100-AA34A9B7-B961-4767-B807-185F5E7B7D1F Q28077130-F42EEC3C-8FC4-4B65-9BA0-30739FD7567B Q30486664-DDFC1385-F240-4987-BA5B-204F7ABBD318 Q33403052-109DDEBA-3615-439E-A48E-9BBFFBD4242E Q33407192-082349F8-C079-4261-ABB9-04F524EE7CDA Q33673888-8B8B2BA8-DAF4-48DC-984A-84FE70F47D10 Q33710278-34F21FA5-A3FD-4902-B127-1B6E23AD58A7 Q33801278-428AE28B-A204-4176-99F0-3282CA899C83 Q34409505-75EA7805-E371-43D6-A4A6-FE74D9ACBA41 Q34966853-D93221BF-F493-4097-9143-1DB10FE35D0B Q35010720-3363687A-0CB2-446B-9B18-92F590CA099E Q35624871-2DBBE88E-535C-4305-B03C-74E471D293B9 Q35674649-CB8D3417-7FE1-407F-85A4-63087405C7C9 Q35731058-F3ADA5EC-D219-47A6-8D48-C679B937C78D Q35814151-78CAE515-9546-4DDA-83B4-C791461B3A6F Q36204525-1FFCF10E-3952-4DF1-B88D-376B5ABB4CB8 Q36479541-C1D8FA7B-49DB-4BC9-8C93-6FADCB7EF894 Q37288114-FDDF30B5-127F-463A-8194-4FF53E00FB67 Q37610871-8B57E3C2-61A2-4FAE-849F-71669592EEE6 Q37853593-68BD47B3-AE40-4DA4-9529-72CB012ED382 Q37877205-07B2BC24-3078-4A6F-8EEC-4C1EBCC4C7DE Q37970443-5F415744-9FB3-4891-B3EB-424D00346775 Q37989298-E7280EA6-9539-438E-9FDE-E3550104C8E8 Q38008173-D9BF339F-9BC8-44BC-B89C-AD41577CE8B0 Q38021493-8B2EB675-87A3-4843-987F-D799ED4CC402 Q38073147-761CD8DB-4AFB-47D0-BAFB-B707DF94454F Q38084182-356FB0F3-E88D-468D-AB2D-B6315367CEC1 Q38099226-D8A3F693-208A-446F-8B62-871FF6C6E163 Q38127143-3F64CF8D-627E-4A24-AA0A-BAC9192F5F26 Q38196327-768618AB-DD96-4752-8AE8-70265C35EFC3 Q38259908-5523EDBC-67FB-4978-B480-8454464316E6 Q38298448-26DCBECD-2C23-4E2A-917E-0FEECA4D5467 Q38388423-FBAF760E-2939-4F9F-B15F-6A60A02A49AB Q38393228-F1623B5E-494D-46B4-B11A-F1F3DDA595BD

P2860

Rituximab plus Peg-interferon-alpha/ribavirin compared with Peg-interferon-alpha/ribavirin in hepatitis C-related mixed cryoglobulinemia.

http://www.wikidata.org/entity/Q50559814

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

2010年學術文章

@zh-hant

name

Rituximab plus Peg-interferon- ...... elated mixed cryoglobulinemia.

@en

Rituximab plus Peg-interferon- ...... elated mixed cryoglobulinemia.

@nl

type

label

Rituximab plus Peg-interferon- ...... elated mixed cryoglobulinemia.

@en

Rituximab plus Peg-interferon- ...... elated mixed cryoglobulinemia.

@nl

prefLabel

Rituximab plus Peg-interferon- ...... elated mixed cryoglobulinemia.

@en

Rituximab plus Peg-interferon- ...... elated mixed cryoglobulinemia.

@nl

P1433

Q50559814-355DA7C7-2B0B-4D58-8DC9-2187E87D3676

P1476

Q50559814-B00826F0-FB80-4EE3-B627-232A431EE6F3

P2093

Q50559814-13C6A7F6-AAAF-4E81-A74C-BAF8E0A97615

Q50559814-2ED4052D-1B07-492F-AAC2-64F99330F757

Q50559814-405C9CE9-C3E1-45C5-AE69-B2EA688CDBB2

Q50559814-4C855395-2EF8-453D-888B-3C061C74834B

Q50559814-75726DFB-31F6-4065-B6FA-875621F42DD8

Q50559814-8FA4676F-6731-4F91-A84D-02860DD6B0E0

Q50559814-949A88A7-70BA-43DE-85F9-957C8619BC98

Q50559814-B9DB59FE-1FE4-4B07-8D21-65833F4D0F7C

Q50559814-D2F58CEA-890A-44D4-A682-5EFFCE01BF1E

Q50559814-FB8C75A7-E3D8-4A6F-9664-613500225677

P304

Q50559814-6FE5C9F5-502C-45A8-80E7-0BCC4AA76721

P31

Q50559814-E0BD82A3-AC32-4A8E-8535-496E229C53DE

P356

Q50559814-EF9731FF-898A-4211-879E-96CB6C4B7B0E

P407

Q50559814-8EC3E336-0BFB-4A65-B672-14C20F81A9D1

P433

Q50559814-23228C5B-9D46-458F-A9E2-F2B81B2011F2

P478

Q50559814-BD4DFD1A-DFE4-4C9F-96D1-E97415BB4166

P50

Q50559814-63F6073D-E57E-4549-9D33-1A02674E73CB

Q50559814-D0007221-31A7-4473-8128-981E64829A94

Q50559814-FFA5B01B-38D8-4B4B-94C7-ADD50317C70E

P577

Q50559814-2CAEEAC0-94F6-4F0A-B1A2-BB84732F8DA6

P698

Q50559814-A6178CFF-D432-454A-B8ED-B734C02E7507

P356

BLOOD-2009-10-248518

P1433

P1476

Rituximab plus Peg-interferon- ...... elated mixed cryoglobulinemia.

@en

P2093

Alexandre Karras

http://www.w3.org/2001/XMLSchema#string

Benjamin Terrier

http://www.w3.org/2001/XMLSchema#string

Brigitte Coppéré

http://www.w3.org/2001/XMLSchema#string

Damien Sene

http://www.w3.org/2001/XMLSchema#string

David Saadoun

http://www.w3.org/2001/XMLSchema#string

François Blanc

http://www.w3.org/2001/XMLSchema#string

Laurent Perard

http://www.w3.org/2001/XMLSchema#string

Lucile Musset

http://www.w3.org/2001/XMLSchema#string

Mathieu Resche Rigon

http://www.w3.org/2001/XMLSchema#string

Yoland Schoindre

http://www.w3.org/2001/XMLSchema#string

P304

326-34; quiz 504-5

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1182/BLOOD-2009-10-248518

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

116

http://www.w3.org/2001/XMLSchema#string

P50

Michelle Rosenzwajg

Jean-Charles Piette

P577

2010-05-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20439619

http://www.w3.org/2001/XMLSchema#string